跳至主要内容
临床试验/EUCTR2011-001191-19-DK
EUCTR2011-001191-19-DK进行中(未招募)不适用

Cardiac effects of inhibition of the renin angiotensin system with losartan in patients with hypertrophic cardiomyopathy.

Hjertemedicinsk klinik B, 2142, Rigshospitalet0 个研究点开始时间: 2011年9月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Known hypertophic cardiomyopathy
  • - > 18 years
  • - Sinus rhythm
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 120

排除标准

  • - Ejection fraction < 50 %
  • - Treatment with inhibitor of the renin angiotensin system within 3 months
  • - Pregnancy or lactation
  • - Renal insufficiency
  • - Liver insufficiency
  • - Hypotension
  • - Not sufficiently treated hypertesnion
  • - Earlier experinced angioneurotic oedema when treated with inhibitor of the renin angiotensin system
  • - Treatment with Lithium
  • - Expected non-compliance

研究者

发起方
Hjertemedicinsk klinik B, 2142, Rigshospitalet

相似试验

Effects on the heart in patients with hypertophic... | 临床试验